ATE532527T1 - Simmondsin zur verwendung als hemmstoff der angiogenese - Google Patents

Simmondsin zur verwendung als hemmstoff der angiogenese

Info

Publication number
ATE532527T1
ATE532527T1 AT03762641T AT03762641T ATE532527T1 AT E532527 T1 ATE532527 T1 AT E532527T1 AT 03762641 T AT03762641 T AT 03762641T AT 03762641 T AT03762641 T AT 03762641T AT E532527 T1 ATE532527 T1 AT E532527T1
Authority
AT
Austria
Prior art keywords
desmethylsimmondsin
ferulate
dimethylsimmondsin
didesmethylsimmondsin
humans
Prior art date
Application number
AT03762641T
Other languages
English (en)
Inventor
Oosterlynck Andre D
Stefaan Raes
Original Assignee
Oosterlynck Andre D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oosterlynck Andre D filed Critical Oosterlynck Andre D
Application granted granted Critical
Publication of ATE532527T1 publication Critical patent/ATE532527T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Botany (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT03762641T 2002-07-08 2003-07-07 Simmondsin zur verwendung als hemmstoff der angiogenese ATE532527T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE2002/0428A BE1015023A3 (fr) 2002-07-08 2002-07-08 L'usage de la farine raffinee et deshuilee du jojoba ou un ou plusieurs de ces composants bio-actives comme agent inhibiteur de l'angiogenese dans la lutte contre le cancer.
PCT/EP2003/007270 WO2004004746A1 (en) 2002-07-08 2003-07-07 Simmondsin for use as an angiogenesis inhibitor

Publications (1)

Publication Number Publication Date
ATE532527T1 true ATE532527T1 (de) 2011-11-15

Family

ID=30005466

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03762641T ATE532527T1 (de) 2002-07-08 2003-07-07 Simmondsin zur verwendung als hemmstoff der angiogenese

Country Status (8)

Country Link
US (1) US7387999B2 (de)
EP (1) EP1526862B1 (de)
AT (1) ATE532527T1 (de)
AU (1) AU2003246395A1 (de)
BE (1) BE1015023A3 (de)
ES (1) ES2376054T3 (de)
IL (1) IL166182A (de)
WO (1) WO2004004746A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1616874A1 (de) * 2004-07-14 2006-01-18 Universiteit Gent Mono- und bicyclische Verbindungen mit therapeutischer Aktivität und pharmazeutische Zubereitungen
US7774275B2 (en) * 2005-02-28 2010-08-10 Searete Llc Payment options for virtual credit
US8617487B2 (en) 2009-03-25 2013-12-31 Venture Lending & Leasing Vi, Inc. Saliva sample collection systems
WO2017191501A2 (en) * 2016-05-04 2017-11-09 D'oosterlynck André Simmondsin formulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1006958A3 (nl) * 1993-04-29 1995-01-31 Ku Leuven Research & Dev Vzw Werkwijze voor het beinvloeden van de voedselopname door mensen en dieren.
BE1008895A6 (nl) * 1994-11-17 1996-08-06 Oosterlynck Andre D Methode voor het afscheiden van de toxische harsachtige fractie uit de voorbereide jojoba noot massa of uit de jojoba perskoek.
EP1616874A1 (de) * 2004-07-14 2006-01-18 Universiteit Gent Mono- und bicyclische Verbindungen mit therapeutischer Aktivität und pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
US7387999B2 (en) 2008-06-17
ES2376054T3 (es) 2012-03-08
IL166182A (en) 2013-08-29
IL166182A0 (en) 2006-01-15
BE1015023A3 (fr) 2004-08-03
US20060088613A1 (en) 2006-04-27
WO2004004746A1 (en) 2004-01-15
AU2003246395A1 (en) 2004-01-23
EP1526862B1 (de) 2011-11-09
EP1526862A1 (de) 2005-05-04

Similar Documents

Publication Publication Date Title
BRPI0515500A (pt) derivados piridazina para inibição de estearoil-coa-desaturase
MA32835B1 (fr) Derives d'acides tetramiques a substitution alcoxy/alkylspirocyclique geminale
EA200200983A1 (ru) Эмульсия, содержащая растительный экстракт, способ изготовления такой эмульсии и способ получения растительного экстракта
DE69912581D1 (de) Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren
ATE517861T1 (de) Benzylether und benzylaminoverbindungen als inhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
BRPI0510623A (pt) compostos de derivados de prolina e morfolina
BRPI0409417A (pt) método para usar um composto, composto, e, composição
Sowemimo et al. Anti-inflammatory activity of Markhamia tomentosa (Benth.) K. Schum. Ex Engl. ethanolic leaf extract
DE60140871D1 (de) Arylmethylamin-derivate zur verwendung als inhibitoren von tryptase
BR0115936A (pt) 2-anilino-benzimidazóis substituìdos e sua aplicação como inibidores de nhe
Singh et al. Hepatoprotective effect of Physalis divaricata in paracetamol induced hepatotoxicity: In vitro, in silico and in vivo analysis
DE60139070D1 (de) Thienodibenzazulenverbindungen als tumornekrosefaktorhemmer
ATE399011T1 (de) Substituierte diketopiperazine als oxytocin- antagonisten
SA522441650B1 (ar) مثبطات فوسفوينوسيتيد 3-كيناز الموضعية
DK1809288T3 (da) Anvendelse af 1,4-bis-(3-aminoalkyl)piperazinderivater ved behandling af neurodegenerative sygdomme
ATE532527T1 (de) Simmondsin zur verwendung als hemmstoff der angiogenese
ATE512147T1 (de) Makrozyklische aminiopyridyl-beta-sekretase- hemmer zur behandlung von morbus alzheimer
NO20050270L (no) Nye forbindelser, deres anvendelse og fremstilling
ES2333026T3 (es) Derivados de ciclohexil-1,4-diamina sustituidos.
RU2008137281A (ru) Профилактическое лечение и ремиссия аллергических заболеваний
BR0313199A (pt) Derivados h de ácido endiândrico como inibidores de c-maf para o emprego contra asma
ATE418980T1 (de) Neue mittel zur prophylaxe und behandlung von erkrankungen in zusammenhang mit beeinträchtigter neurotransmission
Fernández et al. Evaluation of Pluchea carolinensis extracts as antioxidants by the epinephrine oxidation method
MXPA02010362A (es) Composiciones fungicas.
JP2008285424A (ja) プロフィラグリン産生促進剤、フィラグリン産生促進剤及びシクロオキシゲナーゼ−２活性阻害剤